Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.33 USD -1.19%
Market Cap: 37.2m USD

Intrinsic Value

The intrinsic value of one LTRN stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.33 USD, Lantern Pharma Inc. is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

LTRN Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Lantern Pharma Inc.

Intrinsic Value History
Dive into the past to invest in the future

LTRN looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether LTRN usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about LTRN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LTRN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lantern Pharma Inc..

Explain Valuation
Compare LTRN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LTRN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lantern Pharma Inc.

Current Assets 17.2m
Cash & Short-Term Investments 15.9m
Other Current Assets 1.3m
Non-Current Assets 219.5k
PP&E 182.8k
Other Non-Current Assets 36.7k
Current Liabilities 4.9m
Accounts Payable 4.8m
Accrued Liabilities 131.5k
Other Current Liabilities 100
Non-Current Liabilities 13.5k
Other Non-Current Liabilities 13.5k
Efficiency

Free Cash Flow Analysis
Lantern Pharma Inc.

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lantern Pharma Inc.

Revenue
0 USD
Operating Expenses
-20.5m USD
Operating Income
-20.5m USD
Other Expenses
1.3m USD
Net Income
-19.2m USD
Fundamental Scores

LTRN Profitability Score
Profitability Due Diligence

Lantern Pharma Inc.'s profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROIC is Increasing
Low 3Y Average Gross Margin
hidden
Profitability
Score

Lantern Pharma Inc.'s profitability score is hidden . The higher the profitability score, the more profitable the company is.

LTRN Solvency Score
Solvency Due Diligence

Lantern Pharma Inc.'s solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Lantern Pharma Inc.'s solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 20.4 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Lowest
Price Target
15.15 USD
355% Upside
Average
Price Target
20.4 USD
513% Upside
Highest
Price Target
26.25 USD
688% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Lantern Pharma Inc.
does not pay dividends
Shareholder Yield

Current shareholder yield for LTRN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LTRN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LTRN stock?

The intrinsic value of one LTRN stock under the Base Case scenario is hidden USD.

Is LTRN stock undervalued or overvalued?

Compared to the current market price of 3.33 USD, Lantern Pharma Inc. is hidden .

Back to Top